Medscape www.medscape.com

References for:
Treatment of Parkinson's Disease with Ropinirole after Pergolide-Induced Retroperitoneal Fibrosis

[Pharmacotherapy 19(12):1437-1438, 1999. © 1999 Pharmacotherapy Publications]

  1. Watts RL. The role of dopamine agonists in early Parkinson's disease. Neurology 1997;49(suppl 1):S34-48.
  2. Jimenez-Jimenez FJ, Lopez-Alvarez J, Sanchez-Chapado M, et al. Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide. Clin Neuropharmacol 1995;18:277-9.
  3. Kunkler RB, Osborn DE, Abbott RJ. Retroperitoneal fibrosis caused by treatment with pergolide in a patient with Parkinson's disease. Br J Urol 1998;82:147.
  4. Demonet JF, Rostin M, Dueymes JM, Ioualalen A, Montastruc JL, Rascol A. Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine. Clin Neuropharmacol 1986;9:200-1.
  5. Bowler JV, Ormerod IE, Legg NJ. Retroperitoneal fibrosis and bromocriptine. Lancet 1986;2:466.
  6. Herzog A, Minne H, Ziegler R. Retroperitoneal fibrosis in a patient with macroprolactinoma treated with bromocriptine. Br Med J 1989;298:1315.
  7. Murphy F, Pickard RS. Bromocriptine-associated retroperitoneal fibrosis presenting with testicular retraction. Br J Urol 1989;64:318-19.
  8. Hely MA, Morris JGL, Lawrence S, Jeremy R, Genge S. Retroperitoneal fibrosis, skin and pleuropulmonary changes associated with bromocriptine therapy. Aust NZ J Med 1991;21:82-4.
  9. Lepage-Savary D, Vallieres A. Ergotamine as a possible cause of retroperitoneal fibrosis. Clin Pharm 1982;1:179-80.
  10. Graham JR, Suby HI, LeCompte PR, Sadowsky NL. Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med 1966;274:359-68.
  11. Weiss JM, Hinman F. Reversible retroperitoneal fibrosis with ureteral obstruction associated with ingestion of Sansert. J Urol 1966;95:771-5.
  12. Elkind AH, Friedman AP, Bachman A, Siegelman SS, Sacks OW. Silent retroperitoneal fibrosis associated with methysergide therapy. JAMA 1968;206:1041-4.
  13. Gelford GJ, Cromwell DK. Methysergide, retroperitoneal fibrosis and rectosigmoid stricture. Am J Roentgenol Radium Ther 1968;104:566-70.
  14. Stecker JF, Rawls HP, Devine CJ, Devine PC. Retroperitoneal fibrosis and ergot derivatives. J Urol 1974;112:30-2.
  15. Aptekar RG, Mitchinson MJ. Retroperitoneal fibrosis in two patients previously exposed to LSD. California Med 1970;113:77-9.